Drugs / BI 695500
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01950273 | Sep 2013 → Dec 2015 | follicular lymphoma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT02417129 | Apr → Dec 2015 | non-Hodgkin lymphoma | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 3 | NCT01955733 | May 2013 → Nov 2015 | rheumatoid arthritis | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 3 | NCT01682512 | Sep 2012 → Nov 2015 | rheumatoid arthritis | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 695500 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01950273 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT01955733 ↗ |